Online citations, reference lists, and bibliographies.

Iron Oxide Nanoparticles: Diagnostic, Therapeutic And Theranostic Applications

Seyed Mohammadali Dadfar, Karolin Roemhild, Natascha Drude, Saskia von Stillfried, Ruth Knuechel, Fabian Kiessling, Twan Lammers
Published 2019 · Biology, Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
&NA; Many different iron oxide nanoparticles have been evaluated over the years, for a wide variety of biomedical applications. We here summarize the synthesis, surface functionalization and characterization of iron oxide nanoparticles, as well as their (pre‐) clinical use in diagnostic, therapeutic and theranostic settings. Diagnostic applications include liver, lymph node, inflammation and vascular imaging, employing mostly magnetic resonance imaging but recently also magnetic particle imaging. Therapeutic applications encompass iron supplementation in anemia and advanced cancer treatments, such as modulation of macrophage polarization, magnetic fluid hyperthermia and magnetic drug targeting. Because of their properties, iron oxide nanoparticles are particularly useful for theranostic purposes. Examples of such setups, in which diagnosis and therapy are intimately combined and in which iron oxide nanoparticles are used, are image‐guided drug delivery, image‐guided and microbubble‐mediated opening of the blood‐brain barrier, and theranostic tissue engineering. Together, these directions highlight the versatility and the broad applicability of iron oxide nanoparticles, and indicate the integration in future medical practice of multiple iron oxide nanoparticle‐based materials.
This paper references
10.5012/BKCS.2012.33.12.3957
Impact of Amino-Acid Coating on the Synthesis and Characteristics of Iron-Oxide Nanoparticles (IONs)
Alireza Ebrahiminezhad (2012)
10.1002/smll.201201531
Applications and potential toxicity of magnetic iron oxide nanoparticles.
Gang Liu (2013)
10.1038/srep14055
Magnetic Particle Imaging tracks the long-term fate of in vivo neural cell implants with high image contrast
Bo Zheng (2015)
10.1016/j.ultrasmedbio.2007.11.006
Physicochemical characteristics of Sonazoid, a new contrast agent for ultrasound imaging.
Per Christian Sontum (2008)
10.1016/j.kint.2016.12.037
Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.
Gerda B Tóth (2017)
10.1016/j.jconrel.2017.03.006
PBCA‐based polymeric microbubbles for molecular imaging and drug delivery
Patrick Koczera (2017)
10.1089/ars.2012.4785
Redox control of inflammation in macrophages.
Bernhard Brüne (2013)
10.1166/JCSB.2012.1002
Thermally-Sensitive and Magnetic Poly(N-Vinylcaprolactam)-Based Nanogels by Inverse Miniemulsion Polymerization
Simone de Fátima Medeiros (2012)
10.7150/thno.13728
Quantitative Magnetic Particle Imaging Monitors the Transplantation, Biodistribution, and Clearance of Stem Cells In Vivo
Bo Zheng (2016)
10.1148/radiol.12111472
Pseudoprogression of glioblastoma after chemo- and radiation therapy: diagnosis by using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging with ferumoxytol versus gadoteridol and correlation with survival.
Seymur Gahramanov (2013)
10.1016/j.ijbiomac.2017.08.011
Thermo-and pH-sensitive hydrogel membranes composed of poly(N-isopropylacrylamide)-hyaluronan for biomedical applications: Influence of hyaluronan incorporation on the membrane properties.
Elbadawy A. Kamoun (2018)
10.1148/radiol.14131520
Nanoparticles for imaging: top or flop?
Fabian Kiessling (2014)
10.2217/17435889.2.1.23
Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.
Ajay Kumar Gupta (2007)
10.1016/j.ultsonch.2017.08.040
One minute synthesis of amino-silane functionalized superparamagnetic iron oxide nanoparticles by sonochemical method.
Bashiru Kayode Sodipo (2018)
10.1002/nbm.991
Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells.
A. Arbab (2005)
10.1002/jmri.10317
Improvement of image quality of non-invasive coronary artery imaging with magnetic resonance by the use of the intravascular contrast agent Clariscan (NC100150 injection) in patients with coronary artery disease.
Christoph Thomas Klein (2003)
10.1055/a-0664-0431
Phenyl alanine & Tyrosine Amino acids Coated Magnetic Nanoparticles: Preparation and Toxicity study.
Hamed Nosrati (2019)
10.2217/nnm-2016-5001
Design of iron oxide-based nanoparticles for MRI and magnetic hyperthermia.
Cristina Blanco-Andujar (2016)
10.1007/s12282-009-0143-7
High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results
Kosei Kimura (2010)
10.1021/cr068445e
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.
Sophie Laurent (2008)
10.1080/02656730802104757
Clinical applications of magnetic nanoparticles for hyperthermia
Burghard Thiesen (2008)
10.1039/C3TB20528B
In Vivo Nanotoxicity Testing using the Zebrafish Embryo Assay.
Larissa Yokota Rizzo (2013)
10.2478/s13536-012-0048-6
Synthesizing cysteine-coated magnetite nanoparticles as MRI contrast agent: Effect of pH and cysteine addition on particles size distribution
Reza Ahmadi (2012)
10.1021/ar200084x
Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy.
Carlos Tassa (2011)
10.1021/cm049552x
Easy Synthesis and Magnetic Properties of Iron Oxide Nanoparticles
Kyoungja Woo (2004)
10.1515/9783111419787-003
H
Yu-Qin Cao (1824)
10.1016/j.colsurfb.2015.11.007
Synthesis and characterization of a novel pH-thermo dual responsive hydrogel based on salecan and poly(N,N-diethylacrylamide-co-methacrylic acid).
Wei Wei (2015)
10.1002/CHIN.201440223
Progress in Electrochemical Synthesis of Magnetic Iron Oxide Nanoparticles
Donya Ramimoghadam (2014)
10.3390/ijms13055554
Dextran and Polymer Polyethylene Glycol (PEG) Coating Reduce Both 5 and 30 nm Iron Oxide Nanoparticle Cytotoxicity in 2D and 3D Cell Culture
Miao Yu (2012)
10.1002/jmri.21599
Magnetic resonance imaging enhanced by superparamagnetic iron oxide particles: usefulness for distinguishing between focused ultrasound-induced blood-brain barrier disruption and brain hemorrhage.
Hao-Li Liu (2009)
10.1002/jmri.21937
Resovist enhanced MR imaging of the liver: does quantitative assessment help in focal lesion classification and characterization?
Lucia Santoro (2009)
10.1021/nn101643u
Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles.
Jing Hui Huang (2010)
10.1172/JCI44490
An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice.
Anca Sindrilaru (2011)
10.1161/01.CIR.0000068315.98705.CC
Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging
M. Eline Kooi (2003)
10.2214/ajr.182.5.1821181
Blood pool MR angiography of aortic stent-graft endoleak.
Hale Ersoy (2004)
10.1016/j.biomaterials.2010.11.040
Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting.
Adam J. Cole (2011)
10.1182/blood-2015-08-663245
Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.
Francesca Vinchi (2016)
10.2214/ajr.152.4.771
Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T.
Gilles Marchal (1989)
10.1073/pnas.0708338105
High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents
Boris Polyak (2008)
10.1515/9783111576855-009
D
Saskia Bonjour (1824)
Biocom - patibility of Fe 3 O 4 nanoparticles evaluated by in vitro cytotoxicity assays using normal , glia and breast cancer cells
G. J. Jenkins N. Singh (2010)
10.1186/s11671-016-1714-0
Biogenic Fabrication of Iron/Iron Oxide Nanoparticles and Their Application
Khwaja Salahuddin Siddiqi (2016)
10.1158/0008-5472.CAN-10-2070
Image-guided breast tumor therapy using a small interfering RNA nanodrug.
Mohanraja Kumar (2010)
10.1093/brain/awn009
Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement.
Machteld M. Vellinga (2008)
10.1039/b917195a
Human serum albumin coated iron oxide nanoparticles for efficient cell labeling.
Jin Y. Xie (2010)
10.1016/J.JMMM.2012.01.032
Versatile ferrofluids based on polyethylene glycol coated iron oxide nanoparticles
Ward Brullot (2012)
10.1021/CM300301C
Superparamagnetic MFe2O4 (M = Fe, Co, Mn) Nanoparticles: Tuning the Particle Size and Magnetic Properties through a Novel One-Step Coprecipitation Route
Clara Pereira (2012)
10.1016/j.geb.2003.09.006
Preparation
Mark Voorneveld (2004)
P85
Y.-C. Chen (2011)
10.1371/journal.pone.0005663
Monocyte Subset Dynamics in Human Atherosclerosis Can Be Profiled with Magnetic Nano-Sensors
Moritz Wildgruber (2009)
10.1016/j.drudis.2016.06.028
Dendrimer-based magnetic iron oxide nanoparticles: their synthesis and biomedical applications.
Wenjie Sun (2016)
10.1021/am404946v
Assessing the in vivo efficacy of doxorubicin loaded hyaluronan nanoparticles.
Mohammad H. El-Dakdouki (2014)
10.1038/nnano.2016.168
Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues.
Saeid Zanganeh (2016)
10.1081/JCMR-120003953
Three-dimensional magnetic resonance coronary angiography using a new blood pool contrast agent: initial experience.
Willemijn L F Bedaux (2002)
10.2214/AJR.14.13009
A Phase I Dosing Study of Ferumoxytol for MR Lymphography at 3 T in Patients With Prostate Cancer.
B. Turkbey (2015)
10.1016/j.bbrc.2013.10.115
SPION primes THP1 derived M2 macrophages towards M1-like macrophages.
Amit Laskar (2013)
10.2147/IJN.S126530
Tracking stem cells with superparamagnetic iron oxide nanoparticles: perspectives and considerations
Jasmin (2017)
10.1016/j.addr.2010.05.006
Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
Morteza Mahmoudi (2011)
10.3109/14653249.2011.571246
Labeling of mesenchymal stromal cells with iron oxide-poly(l-lactide) nanoparticles for magnetic resonance imaging: uptake, persistence, effects on cellular function and magnetic resonance imaging properties
Gerlinde Schmidtke-Schrezenmeier (2011)
10.1016/J.COLSURFA.2014.12.031
Chitosan (or alginate)-coated iron oxide nanoparticles: A comparative study
Julia Castello (2015)
10.1038/nm.1711
Chip–NMR biosensor for detection and molecular analysis of cells
Hakho Lee (2008)
10.1021/acs.nanolett.6b02261
Magnetic Drug Targeting: Preclinical in Vivo Studies, Mathematical Modeling, and Extrapolation to Humans.
Khuloud T. Al-Jamal (2016)
10.1002/ADFM.201301275
Iron Oxide-labeled Collagen Scaffolds for Non-invasive MR Imaging in Tissue Engineering.
Marianne E. Mertens (2014)
10.1038/jcbfm.2009.192
Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review
Jason S Weinstein (2010)
10.1109/TMI.2014.2375065
Magnetic Particle Imaging With Tailored Iron Oxide Nanoparticle Tracers
R. M. Ferguson (2015)
10.1038/ncomms4097
Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle.
Daniel L. J. Thorek (2014)
10.1007/s00330-007-0712-0
MR angiography with blood pool contrast agents
Jens Bremerich (2007)
10.1016/j.coph.2014.08.002
Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications.
Rongrong Jin (2014)
Current concepts in lymph node imaging.
Maha Torabi (2004)
10.3238/arztebl.2012.0543a
Highly effective.
Donatus Cyron (2012)
10.1177/1352458515607649
Ultra-small superparamagnetic iron oxide enhancement is associated with higher loss of brain tissue structure in clinically isolated syndrome
Adil Maarouf (2016)
10.1016/j.biomaterials.2015.02.068
Polyethylenimine-coated SPIONs trigger macrophage activation through TLR-4 signaling and ROS production and modulate podosome dynamics.
Vladimir Mulens-Arias (2015)
10.1021/acs.chemrev.5b00690
Small Angle X-ray Scattering for Nanoparticle Research.
Tao Li (2016)
Ferucarbotran (Resovist): a new clinically approved RESspecific contrast agent for contrast-enhanced MRI of the liver: properties
P. Reimer (2003)
10.1021/la8036499
Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery.
Marina Talelli (2009)
10.1063/1.4935688
Fundamentals and advances in magnetic hyperthermia
E. A. Périgo (2015)
10.1016/j.jmmm.2005.01.032
Advances in magnetofection—magnetically guided nucleic acid delivery
Ulrike Schillinger (2005)
10.1007/s11051-012-0964-8
Synthesis optimization and characterization of chitosan-coated iron oxide nanoparticles produced for biomedical applications
Gozde Unsoy (2012)
10.1021/nn900918w
Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs.
Tian Xia (2009)
10.1016/j.jconrel.2014.07.059
Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy.
Nathalie Schleich (2014)
10.1155/2016/2795090
The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases
Hor-Yue Tan (2016)
10.1016/j.biomaterials.2014.10.076
USPIO-labeled textile materials for non-invasive MR imaging of tissue-engineered vascular grafts.
Marianne E. Mertens (2015)
In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors.
Moritz F Kircher (2003)
10.1016/j.ejca.2012.09.034
Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer.
Maria Triantafyllou (2013)
10.5923/J.NN.20120206.01
Systematic Review of the Preparation Techniques of Iron Oxide Magnetic Nanoparticles
S. F. Hasany (2013)
10.1016/j.addr.2013.11.013
Recent advances in molecular, multimodal and theranostic ultrasound imaging.
Fabian Kiessling (2014)
10.1007/s11060-005-9059-z
The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma
Andreas Jordan (2005)
10.1007/s11060-010-0389-0
Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme
Klaus Maier-Hauff (2010)
Synthesis and characterization of a novel pH-thermo dual responsive hydrogel based on salecan and poly (N
W. Wei (2015)
10.1016/j.ijpharm.2016.06.119
Toxicity, toxicokinetics and biodistribution of dextran stabilized Iron oxide Nanoparticles for biomedical applications.
N Remya (2016)
10.1021/am400713j
Casein-coated iron oxide nanoparticles for high MRI contrast enhancement and efficient cell targeting.
Jing Huang (2013)
10.3109/03639041003710151
Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent
Chen Yuejian (2010)
10.2214/ajr.155.5.2120963
Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years.
Joseph T. Jr. Ferrucci (1990)
10.1038/nbt720
Magnetic relaxation switches capable of sensing molecular interactions
José Manuel Pérez (2002)
10.1148/radiol.12112694
USPIO-enhanced MR angiography of arteriovenous fistulas in patients with renal failure.
Monica Sigovan (2012)
A multicenter
J. Koda (2002)
Redox control of in fl ammation in macrophages
N. Wang
10.1021/la203992q
Drug-loaded and superparamagnetic iron oxide nanoparticle surface-embedded amphiphilic block copolymer micelles for integrated chemotherapeutic drug delivery and MR imaging.
Jinming Hu (2012)
10.1021/nn405520d
Magnetic Field-Induced T Cell Receptor Clustering by Nanoparticles Enhances T Cell Activation and Stimulates Antitumor Activity
Karlo Perica (2014)
10.1016/J.COLSURFA.2011.04.032
Multifunctional poly(aspartic acid) nanoparticles containing iron oxide nanocrystals and doxorubicin for simultaneous cancer diagnosis and therapy
Hee-Man Yang (2011)
10.1016/j.addr.2011.03.008
Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery.
Challa S. S. R. Kumar (2011)
10.1002/adfm.201401199
Theranostic USPIO-Loaded Microbubbles for Mediating and Monitoring Blood-Brain Barrier Permeation.
Twan Lammers (2015)
10.1148/radiology.193.2.7972768
AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes.
Pierre Vassallo (1994)
10.1016/j.addr.2008.03.014
Multifunctional magnetic nanoparticles for targeted imaging and therapy.
Jason Mccarthy (2008)
Imagingmacrophages with nanoparticles
M. Nahrendorf
10.1016/j.biomaterials.2011.08.053
Polymer encapsulated upconversion nanoparticle/iron oxide nanocomposites for multimodal imaging and magnetic targeted drug delivery.
Haipeng Xu (2011)
Recent advances in molecular
F. Kiessling (2014)
10.1016/J.JMMM.2014.09.005
Endothelial biocompatibility and accumulation of SPION under flow conditions
Jasmin Matuszak (2015)
10.1097/00007890-201007272-00260
Magnetic resonance imaging of pancreatic islets transplanted into the liver in humans.
František Saudek (2010)
10.1259/bjr.20150167
MRI study of atherosclerotic plaque progression using ultrasmall superparamagnetic iron oxide in Watanabe heritable hyperlipidemic rabbits.
Chiyuki Kaneko (2015)
10.1021/nn2048137
Water-soluble iron oxide nanocubes with high values of specific absorption rate for cancer cell hyperthermia treatment.
Pablo Guardia (2012)
10.1515/9783486731620-002
I
John B. Shoven (1824)
10.1016/j.canlet.2008.03.028
Cancer related inflammation: the macrophage connection.
Antonio Sica (2008)
10.2147/IJN.S48979
Stem cell tracking using iron oxide nanoparticles
Elizabeth Bull (2014)
10.1016/S1470-2045(08)70203-1
MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study.
Roel AM Heesakkers (2008)
10.1002/wnan.84
Magnetic nanoparticle biosensors.
Jered B. Haun (2010)
10.1515/9783111576855-016
K
Martin P. Catherwood (1824)
10.1097/01.cot.0000289242.47980.f9
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp (2005)
10.1088/0957-4484/20/13/135101
Thermosensitive liposomes entrapping iron oxide nanoparticles for controllable drug release.
Lin-Ai Tai (2009)
10.1351/goldbook.t06414
TOXICITY
Marina Azevedo (1986)
10.4061/2011/489342
Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians
Jendana Chanyaputhipong (2011)
10.1016/j.addr.2012.10.008
New forms of superparamagnetic nanoparticles for biomedical applications.
Chenjie Xu (2013)
10.1039/c5nr01651g
Synthesis of phase-pure and monodisperse iron oxide nanoparticles by thermal decomposition.
Ryan Hufschmid (2015)
10.1007/s11095-010-0073-2
Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates
Vasco Filipe (2010)
10.1148/radiology.193.3.7972790
Liver MR imaging with iron oxides: toward consensus and clinical practice.
Ralph Weissleder (1994)
10.2967/jnumed.108.053546
Magnetic Tagging of Therapeutic Cells for MRI
Matthew Budde (2009)
10.1016/S1470-2045(09)70025-7
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
Roger Stupp (2009)
10.1148/radiol.15150025
Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging.
Robert J. McDonald (2015)
10.1088/0957-4484/24/1/015603
Preparation and in vitro evaluation of folate-receptor-targeted SPION-polymer micelle hybrids for MRI contrast enhancement in cancer imaging.
Shveta Mahajan (2013)
10.1021/nn300042m
Silver-coated engineered magnetic nanoparticles are promising for the success in the fight against antibacterial resistance threat.
Morteza Mahmoudi (2012)
10.1016/j.biomaterials.2011.07.040
Herceptin functionalized polyhedral oligomeric silsesquioxane - conjugated oligomers - silica/iron oxide nanoparticles for tumor cell sorting and detection.
Yu Mi (2011)
10.1016/j.biomaterials.2010.08.099
Low molecular weight alkyl-polycation wrapped magnetite nanoparticle clusters as MRI probes for stem cell labeling and in vivo imaging.
Gang Liu (2011)
10.1038/ki.2008.496
Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
E. Neuwelt (2009)
10.5040/9781474284028.0024
S
Ashish Kumar (1824)
10.1021/cm021214d
Microemulsion-assisted synthesis of tunable superparamagnetic composites
Pedro Tartaj (2002)
10.1148/radiol.12111416
Assessment of disease activity in multiple sclerosis phenotypes with combined gadolinium- and superparamagnetic iron oxide-enhanced MR imaging.
Thomas Tourdias (2012)
10.1016/S0730-725X(98)00193-3
MR imaging of the liver and spleen: a comparison of the effects on signal intensity of two superparamagnetic iron oxide agents.
F Chen (1999)
10.1088/0957-4484/26/11/115102
Nanocluster of superparamagnetic iron oxide nanoparticles coated with poly (dopamine) for magnetic field-targeting, highly sensitive MRI and photothermal cancer therapy.
Ming Wu (2015)
10.1007/s00330-002-1721-7
Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications
Peter Reimer (2002)
Muckenthaler, Iron induces anti-tumor activity in tumorassociated macrophages
M. Costa da Silva (2017)
10.1016/j.biotechadv.2016.02.001
The use of magnetic nanoparticles in cancer theranostics: Toward handheld diagnostic devices.
László Hajba (2016)
10.2147/VHRM.2008.04.01.1
Gadofosveset-enhanced magnetic resonance angiography
Mathias Goyen (2008)
10.1039/c2nr11554a
Accumulation of magnetic iron oxide nanoparticles coated with variably sized polyethylene glycol in murine tumors.
Esben Kjær Unmack Larsen (2012)
10.3390/molecules22071030
Albumin and Hyaluronic Acid-Coated Superparamagnetic Iron Oxide Nanoparticles Loaded with Paclitaxel for Biomedical Applications
Elena Vismara (2017)
10.1016/J.MEE.2013.02.045
Effect of synthesis conditions on the properties of citric-acid coated iron oxide nanoparticles
Lanfen Li (2013)
10.1016/j.neuroimage.2009.02.037
Microbubbles as a novel contrast agent for brain MRI
Jerry S. Cheung (2009)
10.3402/nano.v1i0.5358
Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)
Neenu Singh (2010)
10.1007/s11051-014-2678-6
T1–T2 Dual-modal MRI contrast agents based on superparamagnetic iron oxide nanoparticles with surface attached gadolinium complexes
Agnieszka Szpak (2014)
10.1016/j.acra.2015.10.021
MR Angiography of Renal Transplant Vasculature with Ferumoxytol:: Comparison of High-Resolution Steady-State and First-Pass Acquisitions.
Michael T. Corwin (2016)
10.1016/J.PARTIC.2016.06.001
Magnetic nanoparticles for environmental and biomedical applications: A review
Leena Mohammed (2017)
A multicenter , phase I / II trial of hepatic intra - arterial delivery of doxorubicin hydrochloride adsorbed to magnetic targeted carriers in patients with hepatocellular carcinoma
A. Venook Koda (2004)
10.1016/B978-0-7020-7222-2.00022-6
V
Michel Millodot (2018)
10.1097/RLI.0b013e3181a0068b
Safety and Tolerability of Ultrasmall Superparamagnetic Iron Oxide Contrast Agent: Comprehensive Analysis of a Clinical Development Program
Hamm Bernd (2009)
10.1016/j.ejrad.2006.06.016
Detection of hepatic metastasis: manganese- and ferucarbotran-enhanced MR imaging.
Jin-Young Choi (2006)
10.1038/sj.gt.3301624
Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo
Friedrich Scherer (2002)
10.1517/14712598.3.5.745
Enhancing and targeting nucleic acid delivery by magnetic force
Christian Plank (2003)
10.1038/nbt1154
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy
I. Jolanda M. Vries (2005)
10.1055/s-0034-1399344
Combined Preclinical Magnetic Particle Imaging and Magnetic Resonance Imaging: Initial Results in Mice.
Michael G. Kaul (2015)
10.1007/s10971-016-3996-1
Iron oxide-silica nanocomposites yielded by chemical route and sol–gel method
Emil Puscasu (2016)
10.1038/nm1486
In vivo imaging of siRNA delivery and silencing in tumors
Zdravka Medarova (2007)
10.2147/IJN.S70488
Magnetic particle imaging: current developments and future directions
Nikolaos Panagiotopoulos (2015)
10.1038/nnano.2011.149
A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy.
Nam-Hyuk Cho (2011)
10.1056/NEJMoa022749
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
Mukesh G Harisinghani (2003)
10.2215/CJN.06011108
Current status of gadolinium toxicity in patients with kidney disease.
Mark A Perazella (2009)
10.1097/WCO.0b013e328352ec45
Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection.
Donatella De Feo (2012)
DNA
S. C. Tan (2009)
10.3390/ma4020448
Iron Oxide Silica Derived from Sol-Gel Synthesis
Adi Darmawan (2011)
10.1016/j.biomaterials.2004.03.016
Characterization of aqueous dispersions of Fe(3)O(4) nanoparticles and their biomedical applications.
Fong-Yu Cheng (2005)
10.1002/CHIN.201636202
Recent Advances in Synthesis and Surface Modification of Superparamagnetic Iron Oxide Nanoparticles with Silica
Bashiru Kayode Sodipo (2016)
10.1016/J.COLSURFA.2013.01.025
The competing effect of ammonia in the synthesis of iron oxide/silica nanoparticles in microemulsion/sol–gel system
Maria Tereza Cortez Fernandes (2013)
10.1021/ja209245v
Synthesis of nonspherical superparamagnetic particles: in situ coprecipitation of magnetic nanoparticles in microgels prepared by stop-flow lithography.
Su Kyung Suh (2012)
10.1680/BBN.12.00014
Magnetic iron oxide nanoparticles: synthesis and applications
Chengyin Fu (2012)
10.1172/JCI44339
Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients.
J. Gaglia (2011)
10.1148/radiol.12120424
Magnetic particle imaging: visualization of instruments for cardiovascular intervention.
J. Haegele (2012)
10.1002/nbm.1038
Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: implications for cellular magnetic resonance imaging.
Edyta Pawelczyk (2006)
10.1364/BOE.3.002500
Silica-coated super paramagnetic iron oxide nanoparticles (SPION) as biocompatible contrast agent in biomedical photoacoustics
Rudolf Alwi (2012)
10.1007/s003300100908
Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging
Yi-Xiang J. Wang (2014)
Comparison of passive, active and magnetic targeting of tumors by theranostic nanoparticles
Nathalie Schleich (2014)
10.1088/0031-9155/61/18/6620
First in vivo traveling wave magnetic particle imaging of a beating mouse heart.
Patrick Vogel (2016)
10.1016/J.MATDES.2017.03.036
Review on magnetic nanoparticles for magnetic nanofluid hyperthermia application
Ziba Hedayatnasab (2017)
10.1016/S0140-6736(05)61503-6
T
Daniel Davies (1998)
SPIO-conjugated
C.-H. Fan (2013)
10.1021/acs.nanolett.7b04209
Targetable Clinical Nanoparticles for Precision Cancer Therapy Based on Disease-Specific Molecular Inflection Points.
Charalambos Kaittanis (2017)
10.1016/j.msec.2017.03.244
pH-responsive poly(aspartic acid) hydrogel-coated magnetite nanoparticles for biomedical applications.
Jaime Vega-Chacón (2017)
10.2147/NSA.S99986
Synthesis, characterization, applications, and challenges of iron oxide nanoparticles
Attarad Ali (2016)
10.1016/J.COLSURFA.2012.12.022
Ferrofluid based on polyethylene glycol-coated iron oxide nanoparticles: Characterization and properties
Sonia García-Jimeno (2013)
10.1016/J.PROGPOLYMSCI.2010.08.005
Iron oxide-based superparamagnetic polymeric nanomaterials: Design, preparation, and biomedical application
Jung Kwon Oh (2011)
10.1021/mp100228v
Nanotheranostics and image-guided drug delivery: current concepts and future directions.
Twan Lammers (2010)
10.1002/smll.201002185
Controlled release of Fe3O4 nanoparticles in encapsulated microbubbles to tumor cells via sonoporation and associated cellular bioeffects.
Fang Yang (2011)
10.21037/qims.2017.02.09
A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging.
Yì Xiáng J Wáng (2017)
10.1002/nbm.924
Iron oxide MR contrast agents for molecular and cellular imaging.
Jeff W. M. Bulte (2004)
10.1148/radiol.14132921
Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging.
Harriet C. Thoeny (2014)
10.2214/AJR.14.12733
Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation.
Alexander J. Neuwelt (2015)
10.1007/s11051-013-1874-0
Effect of surface charge on the colloidal stability and in vitro uptake of carboxymethyl dextran-coated iron oxide nanoparticles
Vanessa Ayala (2013)
10.1515/9783111697888-007
E
Adam S. Opalski (1824)
10.1002/jbm.b.33068
In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting.
M L Mojica Pisciotti (2014)
LETTER TO THE EDITOR: Three-dimensional real-time in vivo magnetic particle imaging
Jürgen Weizenecker (2009)
10.1016/J.EURURO.2006.11.023
Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution.
M Johannsen (2007)
10.1021/nl2001499
Triggered release from liposomes through magnetic actuation of iron oxide nanoparticle containing membranes.
E. Amstad (2011)
10.1016/j.nano.2014.01.011
Local hyperthermia treatment of tumors induces CD8(+) T cell-mediated resistance against distal and secondary tumors.
Seiko Toraya-Brown (2014)
10.1097/01.rli.0000133944.30119.cc
Comparison of the Iron Oxide-Based Blood-Pool Contrast Medium VSOP-C184 With Gadopentetate Dimeglumine for First-Pass Magnetic Resonance Angiography of the Aorta and Renal Arteries in Pigs
Jörg Schnorr (2004)
10.1016/j.ijpharm.2008.08.020
Gelatin-coated magnetic iron oxide nanoparticles as carrier system: drug loading and in vitro drug release study.
Babita Gaihre (2009)
10.1038/nmat3780
Imaging macrophages with nanoparticles.
Ralph Weissleder (2014)
10.1002/jmri.1880040508
Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide.
Bernd A. Hamm (1994)
Synthe - sis , self - assembly , and characterization of PEG - coated iron oxide nanoparticles as potential MRI contrast agent
Yue-Jian
Nanocluster of superparamagnetic iron oxide nanoparticles coated with poly (dopamine) for magnetic fieldtargeting
M. Wu (2015)
10.1002/CHIN.201227257
Designed Synthesis of Uniformly Sized Iron Oxide Nanoparticles for Efficient Magnetic Resonance Imaging Contrast Agents
Nohyun Lee (2012)
10.1016/J.CATCOM.2010.12.032
Studies of Fe3O4-chitosan nanoparticles prepared by co-precipitation under the magnetic field for lipase immobilization
Yong Liu (2011)
10.1016/J.MSEC.2010.01.006
Doxorubicin loaded PVA coated iron oxide nanoparticles for targeted drug delivery
Sibnath Kayal (2010)
10.1002/adma.200401904
Magnetite-Loaded Polymeric Micelles as Ultrasensitive Magnetic-Resonance Probes†
Hua Ai (2005)
10.1102/1470-7330.2009.0004
Detection of lymph node metastases with ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging in oesophageal cancer: a feasibility study
B.B. Pultrum (2009)
10.2214/ajr.182.1.1820235
Detection of malignant hepatic tumors with ferumoxides-enhanced MRI: comparison of five gradient-recalled echo sequences with different TEs.
Masayuki Matsuo (2004)
10.1016/S1525-0016(03)00065-0
Magnetofection--a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo.
Florian Kroetz (2003)
Contrast agents used in MR imaging of the liver.
Nevzat Karabulut (2006)
10.1016/j.biomaterials.2013.01.099
SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery.
Ching-Hsiang Fan (2013)
10.1021/ja017773n
DNA-based magnetic nanoparticle assembly acts as a magnetic relaxation nanoswitch allowing screening of DNA-cleaving agents.
José Manuel Pérez (2002)
10.1007/s00261-008-9402-x
Diagnostic accuracy of MR colonography with fecal tagging
Michael Patrick Achiam (2008)
10.2174/9781608058808114010016
Ultrasound Contrast Agents in Cancer Therapy
Rounak Nande and Pier Paolo Claudio (2014)
10.1016/j.biomaterials.2013.01.084
Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery.
Ru Cheng (2013)
10.1016/J.MATLET.2011.03.065
Fe3O4 magnetic nanoparticles synthesis from tailings by ultrasonic chemical co-precipitation
Shen Rong Wu (2011)
10.1007/s11051-012-1100-5
Improved functionalization of oleic acid-coated iron oxide nanoparticles for biomedical applications
Maarten Bloemen (2012)
10.1155/2009/574398
DNA, RNA, and Protein Extraction: The Past and The Present
Siun Chee Tan (2009)
10.3978/j.issn.2223-4292.2011.08.03
Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application.
Yì Xiáng J Wáng (2011)
10.1148/radiol.2221010225
Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes.
Martin G. Mack (2002)
10.1140/epje/i2006-10051-y
Citric-acid-coated magnetite nanoparticles for biological applications
Mihaela Răcuciu (2006)
10.1016/S0304-8853(98)00556-3
Preparation, relaxometry, and biokinetics of PEGylated magnetoliposomes as MR contrast agent
Jeff W. M. Bulte (1999)
Low molecular weight alkyl-polycation wrapped magnetite nanoparticle clusters as MRI probes for stem cell labeling and in vivo
G. Liu (2011)
10.1088/1468-6996/16/2/023501
Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications
Wei Wu (2015)
10.1517/17425240802662795
Magnetic targeting for site-specific drug delivery: applications and clinical potential.
Boris Polyak (2009)
10.2214/AJR.10.5992
Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging.
B E Hamilton (2011)
10.1038/nrd3578
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
Mark E Lobatto (2011)
10.2217/nnm.14.203
Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors.
Michael Iv (2015)
10.1016/B978-0-12-405191-1.00012-0
Synthesis
Philip R. Wakeley (2013)
10.1016/j.ijrobp.2011.12.093
Value of PET/CT and MR lymphography in treatment of prostate cancer patients with lymph node metastases.
Ansje S Fortuin (2012)
10.1016/j.biomaterials.2013.01.087
Monodisperse magnetite nanoparticle tracers for in vivo magnetic particle imaging.
A. Khandhar (2013)
10.1126/scitranslmed.aac6522
Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle
Miles A. Miller (2015)
10.2214/ajr.180.1.1800227
MR venography using an intravascular contrast agent: results from a multicenter phase 2 study of dosage.
Elna-Marie Larsson (2003)
10.1016/j.colsurfb.2009.08.044
A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles.
Morteza Mahmoudi (2010)
10.1063/1.4896070
Synthesis and characterization of Fe3O4–TiO2 core-shell nanoparticles
Mundt Stefan (2014)
10.1002/adfm.200400187
Large‐Scale Synthesis of Uniform and Crystalline Magnetite Nanoparticles Using Reverse Micelles as Nanoreactors under Reflux Conditions
You Jin Lee (2005)
10.1016/j.ijpharm.2006.10.006
Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate.
Hui-li Ma (2007)
10.1016/j.bbagen.2017.05.019
Ferroptosis: Role of lipid peroxidation, iron and ferritinophagy.
Gladys O Latunde-Dada (2017)
10.1016/j.phrs.2009.12.012
From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications.
Albert Figuerola (2010)
10.1039/B915651H
Magnetoliposomes for controlled drug release in the presence of low-frequency magnetic field
Silvia Nappini (2010)
10.1021/nl061412u
Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems.
Norased Nasongkla (2006)
10.1016/B978-0-12-384931-1.00018-0
R
J. M. Lackie (2013)
10.3109/02656736.2015.1005178
Magnetic nanoparticle hyperthermia enhances radiation therapy: A study in mouse models of human prostate cancer
Anilchandra Attaluri (2015)
10.1002/cmmi.1473
Uniform mesoporous silica coated iron oxide nanoparticles as a highly efficient, nontoxic MRI T(2) contrast agent with tunable proton relaxivities.
Fei Ye (2012)
10.1016/j.tibtech.2011.03.001
Cancer theranostics: the rise of targeted magnetic nanoparticles.
Adam J. Cole (2011)
10.1158/1078-0432.CCR-16-1990
Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study
R. Ramanathan (2017)
10.1021/nn500722y
Multifunctional Fe₃O₄@polydopamine core-shell nanocomposites for intracellular mRNA detection and imaging-guided photothermal therapy.
Lisen Lin (2014)
10.1021/acsnano.8b00893
Magnetic Particle Imaging-Guided Heating in Vivo Using Gradient Fields for Arbitrary Localization of Magnetic Hyperthermia Therapy.
Zhi Wei Tay (2018)
10.1016/j.apsusc.2006.05.023
Oleic acid coating on the monodisperse magnetite nanoparticles
Ling Tao Zhang (2006)
10.1016/j.jconrel.2014.11.024
Iron oxide-loaded nanotheranostics: major obstacles to in vivo studies and clinical translation.
Nathalie Schleich (2015)
10.1002/wnan.1471
Ultra‐small superparamagnetic iron oxides for metastatic lymph node detection: back on the block
Ansje S. Fortuin (2018)
10.1088/0957-4484/22/24/245604
Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.
Fengqin Hu (2011)
Polyethylene glycol modified
A. J. Cole (2011)
10.1039/b902394a
Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications
Ruirui Qiao (2009)
10.1007/978-3-642-24133-8_46
Point Spread Function Analysis of Magnetic Particles
Ingo Schmale (2012)
10.3390/ijms140918682
Design of Superparamagnetic Nanoparticles for Magnetic Particle Imaging (MPI)
Yimeng Du (2013)
10.1517/14656560903224998
Ferumoxytol for treatment of iron deficiency anemia in patients with chronic kidney disease
Daniel W Coyne (2009)
10.1038/icb.2012.72
Imaging macrophage development and fate in atherosclerosis and myocardial infarction.
Filip K Swirski (2013)
10.1088/0034-4885/78/1/016601
Fundamentals and application of magnetic particles in cell isolation and enrichment: a review.
Brian D. Plouffe (2015)
10.3109/17435390.2010.541293
Biomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cells
Fabian Blank (2011)
10.1016/J.NUCLCARD.2007.09.008
Ultrasound molecular imaging with targeted microbubble contrast agents
Alexander L. Klibanov (2007)
10.1088/0031-9155/54/5/L01
Three-dimensional real-time in vivo magnetic particle imaging.
Jürgen Weizenecker (2009)
10.1016/j.cis.2011.04.003
Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles.
Sophie Laurent (2011)
10.1016/J.MATCHAR.2013.04.001
Synthesis and characterization of magnetite nanoparticles coated with lauric acid
Javier Bustamante Mamani (2013)
10.1016/j.biomaterials.2011.08.076
Antibody conjugated magnetic iron oxide nanoparticles for cancer cell separation in fresh whole blood.
Hengyi Xu (2011)
10.1016/J.JMMM.2011.10.017
Ferrite-based magnetic nanofluids used in hyperthermia applications
Ibrahim Sharifi (2012)
10.1016/j.biomaterials.2004.10.012
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
Ajay Kumar Gupta (2005)
10.1016/j.drudis.2017.04.008
Next-generation superparamagnetic iron oxide nanoparticles for cancer theranostics.
Kai Li (2017)
10.1016/j.jallcom.2006.08.311
Biomedical applications of superparamagnetic iron oxide nanoparticles encapsulated within chitosan
Eun Hee Kim (2007)
10.7150/ntno.20564
Prediction of Anti-cancer Nanotherapy Efficacy by Imaging
Miles A. Miller (2017)
10.1371/journal.pone.0190214
Novel magnetic multicore nanoparticles designed for MPI and other biomedical applications: From synthesis to first in vivo studies
Harald Kratz (2018)
10.1002/cbic.200300730
Use of magnetic nanoparticles as nanosensors to probe for molecular interactions.
José Manuel Pérez (2004)
10.1038/nmat1251
Ultra-large-scale syntheses of monodisperse nanocrystals
Jongnam Park (2004)
10.1148/radiol.2301021493
Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/ conventional angiography suite--initial experience with four patients.
Mark Wilson (2004)
10.1097/01.rli.0000129472.45832.b0
Phase I Clinical Evaluation of Citrate-coated Monocrystalline Very Small Superparamagnetic Iron Oxide Particles as a New Contrast Medium for Magnetic Resonance Imaging
Matthias Taupitz (2004)
10.1148/radiol.10100116
Coronary CT versus MR angiography: the role of MR angiography.
Hajime Sakuma (2011)
10.1016/J.MSEB.2012.01.003
Synthesis and characterization of magnetite nanoparticles via the chemical co-precipitation method
Karat Petcharoen (2012)
10.1102/1470-7330.2013.0050
Liver-specific agents for contrast-enhanced MRI: role in oncological imaging
Yee Liang Thian (2013)
10.1161/01.ATV.0000222920.59760.df
Identifying Inflamed Carotid Plaques Using In Vivo USPIO-Enhanced MR Imaging to Label Plaque Macrophages
Rikin Trivedi (2006)
MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis.
L G Remsen (1996)
10.1148/radiol.2392042110
Magnetic targeting of magnetoliposomes to solid tumors with MR imaging monitoring in mice: feasibility.
Jean-Paul Fortin-Ripoche (2006)
10.1515/9783111576855-012
G
G.V.T.V. Weerasooriya (1824)
Conolly, Quantitative magnetic particle imaging monitors the transplantation, biodistribution, and clearance of stem cells
B. Zheng (2016)
Ferroptosis: role of lipid peroxidation
G. O. Latunde-Dada (2017)
10.3389/fimmu.2017.01479
Iron Induces Anti-tumor Activity in Tumor-Associated Macrophages
Milene Costa da Silva (2017)
10.2214/AJR.09.3107
In vivo MRI cell tracking: clinical studies.
Jeff W. M. Bulte (2009)
10.1016/j.colsurfb.2016.02.053
Stimuli-responsive poly(N-isopropyl acrylamide)-co-tyrosine@gadolinium: Iron oxide nanoparticle-based nanotheranostic for cancer diagnosis and treatment.
Ekta Roy (2016)
10.1016/j.ultsonch.2010.08.013
P85, Optison microbubbles and ultrasound cooperate in mediating plasmid DNA transfection in mouse skeletal muscles in vivo.
Yunchao Chen (2011)
10.1002/chin.200924219
Magnetic Iron Oxide Nanoparticles: Synthesis and Surface Functionalization Strategies
Wei Chen Wu (2009)
10.1039/c3tb00369h
Scaling laws at the nanosize
Eric D. Smolensky (2013)
10.1039/c6cc03225g
Gold coated magnetic nanoparticles: from preparation to surface modification for analytical and biomedical applications.
Saimon Moraes Silva (2016)
10.1088/0957-4484/21/7/075102
Biocompatibility of Fe(3)O(4) nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells.
Balaprasad Ankamwar (2010)
10.1016/j.ijpharm.2013.02.042
Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging.
Nathalie Schleich (2013)
10.1039/c3nr00544e
Magnetic particle imaging: advancements and perspectives for real-time in vivo monitoring and image-guided therapy.
Michele H Pablico-Lansigan (2013)
10.1021/nl902715v
A highly effective, nontoxic T1 MR contrast agent based on ultrasmall PEGylated iron oxide nanoparticles.
Ulrich I. Tromsdorf (2009)



This paper is referenced by
10.1186/s12951-020-0580-1
Size-isolation of superparamagnetic iron oxide nanoparticles improves MRI, MPI and hyperthermia performance
Seyed Mohammadali Dadfar (2020)
10.3103/S0027131419060154
Synthesis and Biological Activity of Hybrid Systems of Magnetic Nanoparticles with Antibacterial Drugs
O. I. Vernaya (2019)
10.1016/j.actbio.2019.12.022
Bioactive Iron Oxide Nanoparticles Suppress Osteoclastogenesis and Ovariectomy-induced Bone Loss through Regulating the TRAF6-p62-CYLD Signaling Complex.
Li Liu (2019)
10.1117/1.NPh.7.3.030501
In vivo photoacoustic guidance of stem cell injection and delivery for regenerative spinal cord therapies
Kelsey P. Kubelick (2020)
10.1039/c9me00143c
Protein biomaterials for theranostic applications
Kamia Punia (2019)
10.3390/magnetochemistry5040055
Implication of Magnetic Nanoparticles in Cancer Detection, Screening and Treatment
Oana Hosu (2019)
10.1016/j.actbio.2019.11.027
Targeting Strategies for SuperParamagnetic Iron Oxide Nanoparticles in Cancer Therapy.
Defu Zhi (2019)
10.3390/nano9040494
Fe3O4 Nanoparticles for Complex Targeted Delivery and Boron Neutron Capture Therapy
Kanat Dukenbayev (2019)
10.1002/wnan.1575
Immunoengineering in glioblastoma imaging and therapy.
Steven Zanganeh (2019)
10.1016/j.biomaterials.2019.119545
Radiosensitive core/satellite ternary heteronanostructure for multimodal imaging-guided synergistic cancer radiotherapy.
Hongxing Liu (2019)
10.1016/J.MTLA.2019.100439
Mechanical response of lightweight hollow truss metal oxide lattices
Pawan Kumar Kanaujia (2019)
Magnetoplasmonic nanoparticles for photothermal therapy
Politecnico di Torino (2019)
10.1016/j.msec.2020.110915
Glutamic acid-coated Fe3O4 nanoparticles for tumor-targeted imaging and therapeutics.
Bijaideep Dutta (2020)
10.1002/adma.201904385
Advances in the Application of Magnetic Nanoparticles for Sensing.
Lucy Gloag (2019)
10.1038/s41598-020-59478-2
Bioevaluation of superparamagnetic iron oxide nanoparticles (SPIONs) functionalized with dihexadecyl phosphate (DHP)
Adam Aron Mieloch (2020)
10.1007/s13204-019-01099-x
Biogenic synthesis of iron oxide nanorods using Moringa oleifera leaf extract for antibacterial applications
Samson O. Aisida (2019)
10.1016/j.optcom.2020.125512
Rapid colorimetric and spectroscopy based sensing of mercury by surface functionalized silver nanoparticles in the presence of tyrosine
S. Balasurya (2020)
10.3390/nano10020187
Influence of Magnetic Micelles on Assembly and Deposition of Porphyrin J-Aggregates
Maria Angela Castriciano (2020)
10.1039/c9nh00577c
State-of-the-art iron-based nanozymes for biocatalytic tumor therapy
Meng-Huan Li (2020)
10.1016/j.ijpharm.2020.119098
Nanopharmaceuticals: A focus on their clinical translatability.
Sofia Bisso (2020)
10.3390/nano9111626
Development of Superparamagnetic Nanoparticles Coated with Polyacrylic Acid and Aluminum Hydroxide as an Efficient Contrast Agent for Multimodal Imaging
Manuel Antonio González-Gómez (2019)
10.1088/2053-1591/ab6700
PEGlatyon-SPION surface functionalization with folic acid for magnetic hyperthermia applications
Rodolfo Debone Piazza (2020)
10.1016/j.envres.2019.108574
Combustion and friction-derived nanoparticles and industrial-sourced nanoparticles: The culprit of Alzheimer and Parkinson's diseases.
Lilian Calderón-Garcidueñas (2019)
10.3390/molecules25051029
Small Dimension–Big Impact! Nanoparticle-Enhanced Non-Invasive and Intravascular Molecular Imaging of Atherosclerosis In Vivo
Tobias Lenz (2020)
10.1016/j.jscs.2019.12.004
Synthesis and characterization of magnetite nanoparticles for photocatalysis of nitrobenzene
Victor Alfredo Reyes Villegas (2020)
10.2147/IJN.S205456
Preparation and Characterization of Fe3O4@MTX Magnetic Nanoparticles for Thermochemotherapy of Primary Central Nervous System Lymphoma in vitro and in vivo
Xin-Yu Dai (2019)
10.1007/s12011-020-02034-w
Prospective Protective Effect of Ellagic Acid as a SIRT1 Activator in Iron Oxide Nanoparticle-Induced Renal Damage in Rats
Eman Taha Mohammed (2020)
10.1016/j.ceramint.2020.01.072
γ-Fe2O3 nanoparticles embedded in nanohydroxyapatite matrix for magnetic hyperthermia and in vitro osteoblast cell studies
Juan A. Ramos-Guivar (2020)
10.1016/j.jddst.2019.101447
Synthesis, characterization and in vitro toxicity evaluation of doxorubicin-loaded magnetoliposomes on MCF-7 breast cancer cell line
Alireza Askari (2020)
10.1039/c9nr04967c
Maghemite nanoparticles stabilize the protein corona formed with transferrin presenting different iron-saturation levels.
Ulrike Martens (2019)
10.7150/thno.37184
Cyclic RGD-Functionalized and Disulfide-Crosslinked Iodine-Rich Polymersomes as a Robust and Smart Theranostic Agent for Targeted CT Imaging and Chemotherapy of Tumor
Yan Zou (2019)
10.3390/s20092554
A Guideline for Effectively Synthesizing and Characterizing Magnetic Nanoparticles for Advancing Nanobiotechnology: A Review
Mohammad Reza Zamani Kouhpanji (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar